Endoxan and treatment related secondary malignancy Patient Reports February 12, 2012

Endoxan Side Effects Report #4910745-2
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 03, 2006. Male patient, 38 years of age, was diagnosed with thymoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died.

Endoxan Side Effects Report #4672713-8
Endoxan side effect was reported by a Health Professional from on May 18, 2005. Male patient, 42 years of age, was diagnosed with testis cancer and was treated with Endoxan. After drug was administered, patient experienced the following side effects: treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with BLEOMYCIN, BRIPLATIN, METHOTREXATE, VEPESID, COSMEGEN. Patient recovered.

Endoxan Side Effects Report #4723819-6
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on May 18, 2005. Male patient, 42 years of age, was diagnosed with testis cancer and was treated with Endoxan. After drug was administered, patient experienced the following side effects: treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with BLEOMYCIN, BRIPLATIN, METHOTREXATE, VEPESID, COSMEGEN. Patient recovered.

Endoxan Side Effects Report #4776881-9
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 14, 2005. Female patient, 53 years of age, was diagnosed with systemic lupus erythematosus and was treated with Endoxan. After drug was administered, patient experienced the following side effects: large intestine carcinoma, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with PREDNISOLONE, KOLANTYL, CALCIUM LACTATE, ALFAROL, BEZAFIBRATE, NIVADIL. Patient recovered.


Endoxan Side Effects Report #4952947-5
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2006. Male patient, 62 years of age, was diagnosed with stem cell transplant, diffuse large b-cell lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, CYTARABINE, ADRIACIN, ONCOVIN, CYMERIN. Patient died on 09/08/2000.

Endoxan Side Effects Report #4952948-7
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2006. Male patient, 36 years of age, was diagnosed with stem cell transplant, diffuse large b-cell lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, CYTARABINE, ADRIACIN, ONCOVIN, CYMERIN. Patient died on 01/15/2004.

Endoxan Side Effects Report #4890072-2
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2006. Male patient, 67 years of age, was diagnosed with non-hodgkin's lymphoma stage iv and was treated with Endoxan. After drug was administered, patient experienced the following side effects: leukaemia, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, ADRIBLASTIN, MABTHERA. Patient recovered.

Endoxan Side Effects Report #4906147-5
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 25, 2006. Female patient, 75 years of age, was diagnosed with non-hodgkin's lymphoma stage ii and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, disseminated intravascular coagulation, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, VINCRISTINE SULPHATE, PREDONINE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #4911911-2
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 25, 2006. Female patient, 75 years of age, was diagnosed with non-hodgkin's lymphoma stage ii and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, disseminated intravascular coagulation, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with DOXORUBICIN, LASTET, VINCRISTINE SULPHATE, PREDONINE. Patient was hospitalized. Patient recovered.


Endoxan Side Effects Report #4916999-0
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2006. Male patient, 70 years of age, weighting 180.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: colon cancer, metastasis, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with ADRIBLASTIN, CORTANCYL, ONCOVIN, MABTHERA, PRETERAX, ELISOR, LYSINE ACETYLSALICYLATE, EPOETIN ALFA. Patient recovered.

Endoxan Side Effects Report #4565069-2
Endoxan side effect was reported by a Health Professional from on Jan 19, 2005. Male patient, 66 years of age, weighting 180.8 lb, was diagnosed with non-hodgkin's lymphoma, dermatomyositis and was treated with Endoxan. After drug was administered, patient experienced the following side effects: prostate cancer metastatic, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with ADRIBLASTINA, CORTANCYL, ETOPOSIDE, MABTHERA, VINCRISTINE. Patient recovered.

Endoxan Side Effects Report #4914161-9
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2006. Male patient, 59 years of age, weighting 138.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: gastric cancer, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with ADRIBLASTINE, ETOPOSIDE, NOVANTRONE, FLUDARABINE PHOSPHATE, MABTHERA, ONCOVIN, CORTANCYL. Patient recovered.

Endoxan Side Effects Report #4935889-0
Endoxan side effect was reported by a Consumer or non-health professional from JAPAN on Feb 08, 2006. Male patient, 59 years of age, weighting 138.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: gastric cancer, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, ADRIBLASTINE, NOVANTRONE, FLUDARABINE PHOSPHATE, MABTHERA, ONCOVIN, CORTANCYL. Patient recovered.

Endoxan Side Effects Report #4548533-1
Endoxan side effect was reported by a Health Professional from on Dec 30, 2004. Female patient, 57 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with HOLOXAN, BLEOMYCIN SULPHATE, ETOPOSIDE DAKOTA PHARM, ADRIBLASTINE, ARACYTINE, METHOTREXATE, ELDISINE. Patient was hospitalized. Patient recovered.


Endoxan Side Effects Report #4564533-X
Endoxan side effect was reported by a Health Professional from on Dec 30, 2004. Female patient, 57 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, infection , inflammation, tracheal disorder, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with HOLOXAN, BLEOMYCIN, ETOPOSIDE, ADRIBLASTINE, ARACYTINE, METHOTREXATE, ELDISINE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5062536-2
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2006. Male patient, 74 years of age, was diagnosed with mycosis fungoides and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, cerebral haemorrhage, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, THERARUBICIN, ONCOVIN, PREDNISOLONE. Patient died.

Endoxan Side Effects Report #5085693-0
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2006. Male patient, 74 years of age, was diagnosed with mycosis fungoides and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, cerebral haemorrhage, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, THERARUBICIN, ONCOVIN, PREDNISOLONE, GABEXATE MESILATE. Patient died.

Endoxan Side Effects Report #4883068-8
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 06, 2006. Female patient, 66 years of age, was diagnosed with multiple sclerosis  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: breast cancer female, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with BETASERON, OESCLIM, ESTROGEL, METHOTREXATE, SURGESTONE, LUTENYL, LIVIAL, DANTRIUM. Patient recovered.

Endoxan Side Effects Report #4825512-8
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 02, 2005. Male patient, 71 years of age, was diagnosed with lymphoma  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: gastric cancer, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with PREDONINE. Patient recovered.


Endoxan Side Effects Report #4825701-2
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 02, 2005. Male patient, 71 years of age, was diagnosed with lymphoma  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: gastric adenoma, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with PREDONINE. Patient recovered.

Endoxan Side Effects Report #4827539-9
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 02, 2005. Male patient, 71 years of age, was diagnosed with lymphoma  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: gastric cancer, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with PREDONINE. Patient recovered.

Endoxan Side Effects Report #4827541-7
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 02, 2005. Male patient, 71 years of age, was diagnosed with lymphoma  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: gastric adenoma, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with PREDONINE. Patient recovered.

Endoxan Side Effects Report #4548528-8
Endoxan side effect was reported by a Health Professional from on Dec 30, 2004. Male patient, 39 years of age, was diagnosed with hodgkin's disease nodular sclerosis stage iii and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with BLEOMYCIN SULPHATE, DOXORUBICIN, NATULAN, ETOPOSIDE DAKOTA PHARM, VINCRISTINE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #4592733-1
Endoxan side effect was reported by a Health Professional from on Feb 17, 2005. Female patient, 43 years of age, was diagnosed with hodgkin's disease  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: lymphoma , treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, BLEOMYCIN, PROCARBAZINE, VINBLASTINE SULPHATE, PREDNISOLONE ACETATE. Patient was hospitalized. Patient recovered.


Endoxan Side Effects Report #4985616-6
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2006. Female patient, 28 years of age, was diagnosed with hodgkin's disease , bone marrow transplant  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: breast cancer , treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, DOXORUBICIN, BLEOMYCIN, CISPLATIN, RANIMUSTINE, VINBLASTINE SULPHATE, DACARBAZINE, CYTARABINE. Patient recovered.

Endoxan Side Effects Report #5001638-3
Endoxan side effect was reported by a Consumer or non-health professional from JAPAN on Apr 05, 2006. Female patient, 28 years of age, was diagnosed with hodgkin's disease , bone marrow transplant  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: breast cancer , treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with VEPESID, DOXORUBICIN, BLEOMYCIN, BRIPLATIN, RANIMUSTINE, VINBLASTINE SULPHATE, DACARBAZINE, CYTARABINE. Patient recovered.

Endoxan Side Effects Report #5002244-7
Endoxan side effect was reported by a Consumer or non-health professional from JAPAN on Apr 05, 2006. Female patient, 28 years of age, was diagnosed with hodgkin's disease , bone marrow transplant  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: breast cancer , treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with VEPESID, DOXORUBICIN, BLEOMYCIN, BRIPLATIN, RANIMUSTINE, VINBLASTINE SULPHATE, DACARBAZINE, CYTARABINE. Patient recovered.

Endoxan Side Effects Report #4546089-0
Endoxan side effect was reported by a Health Professional from on Dec 29, 2004. Female patient, 68 years of age, was diagnosed with breast cancer  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acinetobacter infection, acute myeloid leukaemia, acute respiratory distress syndrome, agranulocytosis, respiratory tract infection, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with NOVANTRONE. Patient died on 09/21/2003.

Endoxan Side Effects Report #4955523-3
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2006. Female patient, 42 years of age, was diagnosed with bone marrow transplant , adult t-cell lymphoma/leukaemia and was treated with Endoxan. After drug was administered, patient experienced the following side effects: oesophageal carcinoma, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with PREDONINE, CYTARABINE, ONCOVIN, ETOPOSIDE, ADRIACIN, METHOTREXATE. Patient died.


Endoxan Side Effects Report #4548161-8
Endoxan side effect was reported by a Health Professional from on Dec 30, 2004. Female patient, 26 years of age, weighting 99.21 lb, was diagnosed with b-cell lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, pancytopenia, treatment related secondary malignancy, unevaluable event. Endoxan dosage: 1300 MG DAY 1 AND DAY 2 (C1: 29-DEC, C-2: 13-JAN, C;3 28-JAN-2003) 100 MG 13-FEB-2003 (C4). During the same period patient was treated with IFOSFAMIDE, ADRIBLASTIN, ETOPOSIDE DAKOTA PHARM, MABTHERA, METHOTREXATE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #4951588-3
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 14, 2006. Male patient, 64 years of age, was diagnosed with adult t-cell lymphoma/leukaemia, stem cell transplant and was treated with Endoxan. After drug was administered, patient experienced the following side effects: large intestine carcinoma, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with PREDONINE, ONCOVIN, ETOPOSIDE, ADRIACIN, RANIMUSTINE, VINDESINE, CARBOPLATIN, FLUDARA. Patient recovered.

Endoxan Side Effects Report #4953795-2
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 16, 2006. Male patient, 42 years of age, was treated with Endoxan. After drug was administered, patient experienced the following side effects: graft versus host disease, squamous cell carcinoma, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with PREDONINE, INTERFERON ALFA, MABLIN, TACROLIMUS, GEMCITABINE, VINORELBINE, PACLITAXEL, IRINOTECAN. Patient died on 10/01/2005.

Endoxan Side Effects Report #4548158-8
Endoxan side effect was reported by a Health Professional from on Dec 30, 2004. Male patient, 25 years of age, weighting 141.1 lb, was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, treatment related secondary malignancy. Endoxan dosage: CY. 1-4 = 2400MG, CY 4-8 = 1100 MG (DAY 1). During the same period patient was treated with BLEOMYCIN SULPHATE, ADRIBLASTINE, NATULAN, ETOPOSIDE DAKOTA PHARM, VINCRISTINE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #4554217-6
Endoxan side effect was reported by a Health Professional from on Dec 30, 2004. Male patient, 25 years of age, weighting 141.1 lb, was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, treatment related secondary malignancy. Endoxan dosage: CY. 1-4 = 2400MG, CY 4-8 = 1100 MG (DAY 1). During the same period patient was treated with BLEOMYCIN, ADRIBLASTINE, NATULAN, ETOPOSIDE, VINCRISTINE. Patient was hospitalized. Patient recovered.


Endoxan Side Effects Report #4563622-3
Endoxan side effect was reported by a Health Professional from on Dec 30, 2004. Male patient, 25 years of age, weighting 141.1 lb, was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, treatment related secondary malignancy. Endoxan dosage: CY. 1-4 = 2400MG, CY 4-8 = 1100 MG (DAY 1). During the same period patient was treated with BLEOMYCIN SULPHATE, ADRIBLASTINE, NATULAN, ETOPOSIDE, VINCRISTINE. Patient was hospitalized. Patient recovered.